TNSN05118A1 - Daily melatonin dosing units - Google Patents
Daily melatonin dosing unitsInfo
- Publication number
- TNSN05118A1 TNSN05118A1 TNP2005000118A TNSN05118A TNSN05118A1 TN SN05118 A1 TNSN05118 A1 TN SN05118A1 TN P2005000118 A TNP2005000118 A TN P2005000118A TN SN05118 A TNSN05118 A TN SN05118A TN SN05118 A1 TNSN05118 A1 TN SN05118A1
- Authority
- TN
- Tunisia
- Prior art keywords
- dosing units
- daily melatonin
- daily
- melatonin
- melatonin dosing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
- A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/87—Application Devices; Containers; Packaging
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Chemical & Material Sciences (AREA)
- Alternative & Traditional Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Birds (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10250646A DE10250646A1 (de) | 2002-10-30 | 2002-10-30 | Melatonin in kosmetischen Formulierungen |
PCT/EP2003/012099 WO2004039369A1 (de) | 2002-10-30 | 2003-10-30 | Melatonin-tagesdosierungseinheiten |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN05118A1 true TNSN05118A1 (en) | 2007-05-14 |
Family
ID=32103188
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNP2005000118A TNSN05118A1 (en) | 2002-10-30 | 2005-04-27 | Daily melatonin dosing units |
TNP2005000117A TNSN05117A1 (en) | 2002-10-30 | 2005-04-27 | Formulations containing melatonin, ginkgo biloba, and biotin |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNP2005000117A TNSN05117A1 (en) | 2002-10-30 | 2005-04-27 | Formulations containing melatonin, ginkgo biloba, and biotin |
Country Status (3)
Country | Link |
---|---|
DE (1) | DE10250646A1 (de) |
ES (1) | ES2353865T5 (de) |
TN (2) | TNSN05118A1 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20180311130A1 (en) * | 2015-07-31 | 2018-11-01 | Isdin, S.A. | Anti-hair loss lotion |
WO2020117997A1 (en) * | 2018-12-05 | 2020-06-11 | The Procter & Gamble Company | Container for personal health compositions |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4444238A1 (de) * | 1994-12-13 | 1996-06-20 | Beiersdorf Ag | Kosmetische oder dermatologische Wirkstoffkombinationen aus Zimtsäurederivaten und Flavonglycosiden |
US6524619B2 (en) * | 2000-01-27 | 2003-02-25 | Chronorx, Inc. | Dosage forms useful for modifying conditions and functions associated with hearing loss and/or tinnitus |
-
2002
- 2002-10-30 DE DE10250646A patent/DE10250646A1/de not_active Withdrawn
-
2003
- 2003-10-30 ES ES03769477.5T patent/ES2353865T5/es not_active Expired - Lifetime
-
2005
- 2005-04-27 TN TNP2005000118A patent/TNSN05118A1/en unknown
- 2005-04-27 TN TNP2005000117A patent/TNSN05117A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
ES2353865T3 (es) | 2011-03-07 |
ES2353865T5 (es) | 2017-10-10 |
TNSN05117A1 (en) | 2007-05-14 |
DE10250646A1 (de) | 2004-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA05004535A (es) | Unidad para dosificacion diaria de melatonina. | |
WO2004021968A3 (en) | Solution for ungual application | |
TWI345979B (en) | Topical pharmaceutical compositions for the treatment of dermatitis | |
HK1073997A1 (en) | Administration of agents for the treatment of inflammation | |
TW200510375A (en) | New compounds | |
DE50310516D1 (de) | Fredericamycin-derivate | |
MXPA03010134A (es) | Derivados de ciclohexan-1-4-diamina sustituidos. | |
AU9163701A (en) | Topical composition containing at least one vitamin D or one vitamin D analogue and at least one corticosteroid | |
MY140840A (en) | Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals | |
MX2010006204A (es) | Derivados de oxindol 5,6-disubstituidos y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina. | |
GB0002336D0 (en) | Medicaments | |
WO2004091591A3 (fr) | Composition nutritionnelle ou therapeutique contenant le compose oleurofeine ou l'un de ses derives | |
AU2003273843A8 (en) | Use of skin-protecting substances | |
TW200507838A (en) | Active substance combination comprising a 2,5-dihydroxybenzenesulfonic compound and a potassium ion channel modulator | |
TW200511999A (en) | Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and parathyroid hormone | |
TNSN05118A1 (en) | Daily melatonin dosing units | |
TW200503785A (en) | Dosage form containing (S)-pantoprazole as active ingredient | |
CY1111179T1 (el) | Μοναδες ημερησιας δοσολογιας μελατονινης | |
BRPI0507985A (pt) | derivados de piperazina uréia para o tratamento de endometriose | |
SE0203817D0 (sv) | New composition | |
MY137953A (en) | New association of an anti-atherothrombotic agent and an anti-platelet-aggregation agent | |
GEP20074259B (en) | Nasal pharmaceutical composition of piribedil | |
MXPA03010920A (es) | Uso de alconil l- carnitina para preparacion de medicamento para tratar anhedonia. | |
AU2003298203A1 (en) | Medicaments containing substituted 2,5-diaminomethyl-1h-pyrroles | |
AU2003208288A1 (en) | Deuterated biphenyl-substituted benzimidazoles and medicament containing said compounds for the treatment of hypertonia |